Skip to main content
ConductScienceScienceDex

Mark E Lindsay

NIH Rank #1512
Unclaimed recordClaim profile
  • Program Leader
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2084897Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.5M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#1,512
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Mark E Lindsay. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Mark E Lindsay as a PI. Multi-PI records show the full award amount for context.

  • 1U01NS142895-01A1U01
    Targeted Gene Repair Therapy for Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) Caused by ACTA2 R179H Mutation
    Massachusetts General Hospital
    $2.5M
    award amount

Award organization

Organizations that administered FY2026 awards listing Mark E Lindsay as a PI.

FY2026 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Program/Center Grant Leader
  5. 2026
    $2M Cumulative Funding
  6. 2026
    Entered Top 50% Nationally
    Ranked #1512
  7. 2026
    Entered Top 25% Nationally
    Ranked #1512
  8. 2026
    Entered Top 10% Nationally
    Ranked #1512

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Mark E Lindsay.

Patricia L Musolino
Massachusetts General Hospital
3
shared awards

Explore further

Find collaborators for Mark E Lindsay

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →